FDA Drug Application (022020) for PROTONIX by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number022020
Product Number001
FormFOR SUSPENSION, DELAYED RELEASE;ORAL
DosageEQ 40MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePROTONIX
Active IngredientPANTOPRAZOLE SODIUM

Active IngredientCount
List of drugs with Active Ingredient PANTOPRAZOLE SODIUM3


Back to FDA Applications sponsored by WYETH PHARMS INC